The contraception needs of the perimenopausal woman
- PMID: 24990143
- DOI: 10.1016/j.bpobgyn.2014.05.006
The contraception needs of the perimenopausal woman
Abstract
Perimenopausal women have low fertility but must still be advised to use contraception until natural sterility is reached if they are sexually active. Patterns of contraceptive use vary in different countries worldwide. Long-acting reversible contraceptive methods offer reliable contraception that may be an alternative to sterilisation. Hormonal methods confer significant non-contraceptive benefits, and each individual woman should weigh up the benefits and risks of a particular method. No method of contraception is contraindicated by age alone, although combined hormonal contraception and injectable progestogens are not recommended for women over the age of 50 years. The intrauterine system has particular advantages as a low-dose method of effective hormonal contraception, which also offers control of menstrual dysfunction and endometrial protection in women requiring oestrogen replacement. Condoms are recommended for personal protection against sexually transmitted infections in new relationships. Standard hormone replacement therapy is not a method of contraception.
Keywords: hormonal contraception; hormone replacement therapy; intra-uterine contraception; non-contraceptive benefits; perimenopause.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Comment in
-
The contraceptive needs of the perimenopausal woman.Climacteric. 2014 Dec;17(6):723-4. Climacteric. 2014. PMID: 25562077 No abstract available.
-
Use of the levonorgestrel intrauterine system in postmenopause.Climacteric. 2015 Jun;18(3):431-2. doi: 10.3109/13697137.2014.993828. Climacteric. 2015. PMID: 25966862 No abstract available.
-
Author's reply: To PMID 24990143.Climacteric. 2015 Jun;18(3):432-3. doi: 10.3109/13697137.2014.993830. Climacteric. 2015. PMID: 25966863 No abstract available.
-
Levonorgestrel and breast cancer risk - clarified.Climacteric. 2015 Jun;18(3):434. doi: 10.3109/13697137.2015.1013746. Climacteric. 2015. PMID: 25966864 No abstract available.
Similar articles
-
Contraception during the perimenopause.Maturitas. 2013 Nov;76(3):235-42. doi: 10.1016/j.maturitas.2013.07.009. Epub 2013 Aug 8. Maturitas. 2013. PMID: 23932427 Review.
-
Hormonal contraceptive regimens in the perimenopause.Maturitas. 2009 Jul 20;63(3):204-12. doi: 10.1016/j.maturitas.2009.05.001. Epub 2009 Jun 12. Maturitas. 2009. PMID: 19524378 Review.
-
Contraception during perimenopause.Eur J Contracept Reprod Health Care. 2005 Mar;10(1):19-25. doi: 10.1080/13625180400020861. Eur J Contracept Reprod Health Care. 2005. PMID: 16036294 Review.
-
Long-term benefits and risks of alternative methods of fertility control in the United States.Contraception. 1994 Jul;50(1):1-16. doi: 10.1016/0010-7824(94)90076-0. Contraception. 1994. PMID: 7924318
-
Contraception and hormonal management in the perimenopause.J Womens Health (Larchmt). 2015 Jan;24(1):3-10. doi: 10.1089/jwh.2013.4544. Epub 2014 Apr 28. J Womens Health (Larchmt). 2015. PMID: 24773233 Review.
Cited by
-
Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis.Cancers (Basel). 2023 Nov 28;15(23):5624. doi: 10.3390/cancers15235624. Cancers (Basel). 2023. PMID: 38067328 Free PMC article. Review.
-
Unintended pregnancy: a framework for prevention and options for midlife women in the US.Womens Midlife Health. 2017 Sep 15;3:8. doi: 10.1186/s40695-017-0027-5. eCollection 2017. Womens Midlife Health. 2017. PMID: 30766709 Free PMC article.
-
Contraception pathway: application for midlife women.Womens Midlife Health. 2017 Oct 24;3:10. doi: 10.1186/s40695-017-0029-3. eCollection 2017. Womens Midlife Health. 2017. PMID: 30766710 Free PMC article. Review.
-
Premenstrual Mood Symptoms in the Perimenopause.Curr Psychiatry Rep. 2021 Oct 6;23(11):73. doi: 10.1007/s11920-021-01285-1. Curr Psychiatry Rep. 2021. PMID: 34613495 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical